Document Detail


Antisense oligonucleotide-mediated inhibition of hTERT, but not hTERC, induces rapid cell growth decline and apoptosis in the absence of telomere shortening in human prostate cancer cells.
MedLine Citation:
PMID:  15737568     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Recent evidence points to a novel function of human telomerase reverse transcriptase (hTERT) in promoting tumour cell survival, which might be independent of the telomere-elongating activity of the enzyme. To test this hypothesis, we evaluated comparatively the effects of telomerase inhibition, accomplished through antisense oligonucleotide-mediated interference with hTERT or human telomerase RNA component (hTERC), on the proliferative potential of DU145 human prostate cancer cells. Exposure of cells to a 2'-O-methyl-RNA phosphorothioate oligonucleotide targeting a splicing site within hTERT pre-mRNA induced almost complete inhibition of telomerase activity as a consequence of a marked reduction of the hTERT mRNA expression level, an early decline of DU145 cell growth and apoptotic cell death without any appreciable telomere shortening. Conversely, exposure of DU145 cells to a 2'-O-methyl-RNA phosphorothioate oligonucleotide targeting the template region of hTERC failed to interfere with cell proliferation in spite of the almost complete abrogation of telomerase activity. These results extend and corroborate earlier evidence in favour of an enzymatic activity-independent mechanism by which hTERT maintains tumour cell survival and proliferation.
Authors:
Marco Folini; Cinzia Brambilla; Raffaella Villa; Paolo Gandellini; Sara Vignati; Francesco Paduano; Maria Grazia Daidone; Nadia Zaffaroni
Related Documents :
15664728 - Replicative senescence in sheep fibroblasts is a p53 dependent process.
10982178 - Incidence of mosaic cell lines in vivo and malsegregation of chromosome 21 in lymphocyt...
16473138 - The telomerase inhibitor telomestatin induces telomere shortening and cell death in ara...
12640658 - Cellular senescence in the pathogenesis of benign prostatic hyperplasia.
19910678 - Hydrogen peroxide regulates the mitochondrial content of uncoupling protein 5 in colon ...
22331008 - Photo catalogue for the classification of foci in the balb/c 3t3 cell transformation as...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2005-01-20
Journal Detail:
Title:  European journal of cancer (Oxford, England : 1990)     Volume:  41     ISSN:  0959-8049     ISO Abbreviation:  Eur. J. Cancer     Publication Date:  2005 Mar 
Date Detail:
Created Date:  2005-03-01     Completed Date:  2005-05-03     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  9005373     Medline TA:  Eur J Cancer     Country:  England    
Other Details:
Languages:  eng     Pagination:  624-34     Citation Subset:  IM    
Affiliation:
Dipartimento di Oncologia Sperimentale, Istituto Nazionale per lo Studio e la Cura dei Tumori, Via Venezian 1, 20133 Milan, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Apoptosis
Cell Division
Cell Line, Tumor
DNA-Binding Proteins
Humans
Male
Oligonucleotides, Antisense / pharmacology*
Prostatic Neoplasms / genetics*,  pathology
Telomerase / antagonists & inhibitors*,  metabolism
Telomere / pathology*
Chemical
Reg. No./Substance:
0/DNA-Binding Proteins; 0/Oligonucleotides, Antisense; EC 2.7.7.49/Telomerase

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Thiopurine methyltransferase in acute lymphoblastic leukaemia: biochemical and molecular biological ...
Next Document:  Imbalance of the mitochondrial pro- and anti-apoptotic mediators in neuroblastoma tumours with unfav...